Stay updated on Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page
- Check2 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; no visible changes to content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded a centralized Locations section with entries for multiple US states and Canadian provinces, and removed the prior separate state/province location pages.SummaryDifference0.6%

- Check53 days agoChange DetectedPublications section text updated to indicate PubMed entries are auto-filled and may not relate to the study, and the page revision was updated to v3.3.2. The older PubMed-source description and the v3.2.0 revision note were removed.SummaryDifference0.0%

- Check60 days agoChange DetectedNotice about a lapse in government funding and related operating status messaging was removed from the page. The page now displays the study details without that status notice.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page shows only minor non-substantive updates such as layout tweaks and a recent update timestamp; the core study details and outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check103 days agoChange Detected- Added a government funding lapse notice with operating status guidance and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%

Stay in the know with updates to Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.